Fig. 1From: Sutureless Biological Aortic Valve Replacement (Su-AVR) in Redo operations: a retrospective real-world experience report of clinical and echocardiographic outcomesLeft ventricular ejection fraction improvement at median 24-month follow-upBack to article page